Thursday, June 11, 2020

[ASAP] An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy

TOC Graphic

Nano Letters
DOI: 10.1021/acs.nanolett.0c00953


from Nano Letters: Latest Articles (ACS Publications) https://ift.tt/3dV5EOx
via IFTTT
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)